Episode 16 - Psychosocial burden, impact of illness perceptions and stigma in AA

In this episode of BJD Talks, Sam and Meera discuss the article ‘Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study’ by Christou et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljaf189 

*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists* 

Transcript

SPEAKER_00 0:00

Welcome to BJD Talks, the official podcast of the BJD. I'm Sam.

SPEAKER_01 0:04

And I'm Mira. In this episode, we will be discussing the article by Evangelos Christou et al. Psychosocial Burden and the Impact of Illness Perceptions and Stigma on Quality of Life, Anxiety and Depression in alopecia ariata. Results from the alopecia and me study from July 2025.

SPEAKER_00 0:25

This study addresses an often overlooked aspect of dermatology, how illness perceptions and stigma deeply affect patients with alopecia ariata. While alopecia areata involves chronic immune-mediated non-scarring hair loss, from smaller patches to total scalp and body loss, the psychosocial challenges are equally significant.

SPEAKER_01 0:45

Exactly. The research study highlights that illness perceptions and stigma have more impact on quality of life, anxiety and depression than the severity of the hair loss itself. That's quite transformative, as it shifts the priority from simply addressing the visual aspects of the condition to considering patients' mental well-being.

SPEAKER_00 1:05

The study involved 596 patients across the UK and was conducted between 2021 and 2024. Patients completed an online questionnaire with validated tools like the Dermatology Life Quality Index and the Hospital Anxiety and Depression Scale, alongside measures for stigma and illness perceptions. What is noteworthy is the identification of two distinct patient profiles. Can you tell us more, Mira?

SPEAKER_01 1:32

Yes, the coping and distressed profiles. Those in the coping group had more positive perceptions of their illness, lower stigma, and better mental health outcomes. Contrastingly, those in the distressed group had highly negative perceptions, worse quality of life, and higher anxiety and depression, with stigma playing a key role. What is important to note is that these two groups did not differ in the clinical severity or duration of their alopecia.

SPEAKER_00 2:00

These findings show that how one perceives their illness might matter more than the actual extent of hair loss. Questions like how much does it affect my life? How much does it affect me emotionally? Or how worried am I about it, play a critical role. How should clinicians respond to this?

SPEAKER_01 2:19

Dermatologists should routinely assess illness perceptions and stigma and tailor interventions accordingly. Cognitive behavioural approaches can help reframe negative illness views, while counselling and public awareness campaigns challenging stereotypes could reduce stigma.

SPEAKER_00 2:36

Absolutely. The study also pointed out the perception of low personal and treatment control as a significant concern, where some patients feel they have little or no control over their condition or doubt treatment efficacy. Addressing these gaps is vital. What's the way forward?

SPEAKER_01 2:53

Well, current treatment options for alopecia areata remain limited, which can compound the sense of hopelessness. Targeted psychological interventions might help reshape these perceptions. Simultaneously, advocacy for better therapeutic innovations is essential.

SPEAKER_00 3:09

Good point. The study does have some limitations though. It's cross-sectional, so while associations are identified, causality cannot be established. And the predominance of women and white participants limits generalizability. Exploring more diverse populations and longitudinal data would be valuable next steps.

SPEAKER_01 3:29

Certainly, but it still sends a compelling message. Treating visible symptoms is only half the story. By addressing stigma and negative illness perceptions, we could make significant strides in improving patients' quality of life and mental health.

SPEAKER_00 3:44

Dermatologists and researchers alike should take these findings into their practice and future studies. The next challenge is testing interventions that use this psychological framework.

SPEAKER_01 3:53

Exactly. Thanks for joining us. Be sure to subscribe to BJD Talks for more coverage of research that tackles dermatology's complexities. Thanks for listening.

SPEAKER_00 4:03

And thank you, Mira, for a great discussion. Until next time, take care.